TFmed 2026 features a dynamic, transdisciplinary four-day program focused on proxidrugs (e.g., PROTACs and molecular glues), nucleic acid-based strategies (mRNA and antisense technologies), and cell therapies, with applications across cardiology, diabetes, ageing, inflammation, infection, cancer and neurodegeneration.

The meeting is aimed at researchers, clinicians, and industry professionals. Participants can expect in-depth scientific sessions, direct exchange with speakers, and dedicated opportunities to connect and initiate new collaborations, including networking formats, poster sessions and selected talks, with a strong emphasis on early-career scientist engagement.

​TFmed 2026 is co-organized by the BMFTR-funded Clusters4Future PROXIDRUGS, curATime, and CNATM.

Sessions:

• SESSION I: Proximity-induced modulation & mRNA
• SESSION II: Computational medicine & AI medicine
• SESSION III: Immune-based therapies
• SESSION IV: Therapeutic resistance
• SESSION V: Cardiovascular therapeutics
• SESSION VI: Targeting cancer
• SESSION VII: Limiting inflammation & aging
• SESSION VIII: Future challenges in translational medicine
• POSTER SESSIONS

The conference is sponsored by Technologieland Hessen.

Further information and registration